GW Pharmaceuticals PLC (NASDAQ:GWPH)

152.86
Delayed Data
As of Aug 21
 +2.01 / +1.33%
Today’s Change
90.14
Today|||52-Week Range
196.00
+56.96%
Year-to-Date

Today’s Trading

Previous close150.85
Today’s open151.75
Day’s range151.18 - 155.26
Volume325,435
Average volume (3 months)413,370
Market cap$4.8B
Data as of 4:00pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)-45.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+42.59%
Revenue growth (last year)+48.41%
P/E ratioNM
Price/Sales178.39
Price/Book6.79

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+1.23+1.33%
ALLKAllakos Inc+1.73+1.97%
ACADACADIA Pharmaceutica...+0.55+1.88%
HZNPHorizon Therapeutics...+0.38+1.38%
Data as of 4:00pm ET, 08/21/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$15.5M
Annual profit (last year)-$272.7M
Net profit margin-1,760.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts